Analysts take aim at Woodford over late disclosure of WPCT sell down

Speculation trust could be wound up

David Brenchley
Neil Woodford

Neil Woodford

Neil Woodford has been criticised by investment trust analysts for the late disclosure of the sale of a majority of his stake in Woodford Patient Capital Trust (WPCT), with a trio of brokers speculating the portfolio could be wound up.

In separate announcements to the market on Monday morning (29 July), the board of WPCT said it was considering sacking Woodford Investment Management (WIM) from the running of the trust. It added it had had preliminary discussions with interested third-party candidates. It also said Woodford had informed them he had sold 60% of his holding in the trust, which amounted to 1.75m shares, between 3 July and 8 July for personal reasons, including a tax liability. He now owns around 1.25m shares, representing 0.14% of the issued share capital. But many questioned both why Woodford needed to...

To continue reading this article...

Join Investment Week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now


Already an Investment Week